2017 Anti-Doping Rule Violations (ADRVs) Report / World Anti-Doping Agency (WADA). - Montreal : WADA, 2019.
- Report compiled based on cases received by WADA before 31 May 2019
This is the fifth year that WADA publishes the ADRVs Report. The Report illustrates doping offencescommitted under the World Anti-Doping Code (Code) in 2017.
The Report includes the decisions received by WADA before 31 May 2019 of all Adverse AnalyticalFindings (AAFs) for which the samples were collected by Anti-Doping Organizations (ADOs) in 2017and reported in ADAMS. This also includes Non-Analytical Anti-Doping rule violations for decisionsrendered in 2017. Discrepancy from ADOs’ published statistics may occur due to different reportingcriteria.
The ADRVs Report is divided as follows:
1.) An Introduction and an Executive Summary which provide an overview and highlight the key observations of the 2017 ADRVs Report.
2.) Sections 1 and 2 present the results management outcomes (including ADRVs) of all AAFs detected by WADA-accredited Laboratories for samples collected from athletes in- and out-of-competition in 2017. They are presented by sport, discipline (Section 1) and testing authority (Section 2).
3.) Section 3 includes ADRVs that resulted from Non-Analytical findings committed by Athletes (presented by sport and nationality) and by Athlete Support Personnel (presented by nationality).
4.) Section 4 indicates the total number of ADRVs from Athletes in 2017, which includes AAFs that resulted in an ADRV and all Non-Analytical ADRVs. The data is presented by sport andnationality.
The information is further divided into:
- Sample type (urine or blood),
- Type of test (in- or out-of-competition), and;
- Athlete gender.
Contents:
Introduction
Executive Summary
Section 1: Outcomes of 2017 AAFs by Sport Category
Section 2: Outcomes of 2017 AAFs by Testing Authority Category
Section 3: Report of 2017 Non-Analytical ADRVs
Section 4: Report of 2017 Total Analytical and Non-Analytical ADRVs
